BIOCEPT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | -.--% |
|
-.--% | -99.76% |
| 26/04 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
| 02/04 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 262 | - | - | - | - | - | |
| 1.2TCr | ||||||
| 799.75Cr | ||||||
| 584.85Cr | ||||||
| 553.81Cr | - | - | ||||
| 384.36Cr |
- Stock Market
- Equities
- BIOCQ Stock
- Charts Biocept, Inc.
- Sector Chart
